Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2011
A look at financing, M&A, and alliance activity October–December 2011
Biopharmaceutical company financings more than doubled to $2.7 billion from Q3. There were 23 acquisitions bringing in a total of $17.7 billion. And in alliances there was a focus on biosimilars, oncology and neurology deals, and unique partnerships with clear paths to exits.